Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
CME
|
Timothy Francis Mc Court
Sr MD Global Head Equity & FX |
BUY
Grant, award, or other acquisition
|
Direct | 3,088 Added 26.31% |
$674,820
$218.53 p/Share
|
Sep 16
2024 |
CME
|
Michael G. Dennis
Global Head of Fixed Income |
BUY
Grant, award, or other acquisition
|
Direct | 2,744 Added 30.28% |
$599,646
$218.53 p/Share
|
Sep 16
2024 |
CME
|
Jonathan L Marcus
Sr MD General Counsel |
BUY
Grant, award, or other acquisition
|
Direct | 2,744 Added 27.14% |
$599,646
$218.53 p/Share
|
Sep 16
2024 |
CME
|
Hilda Harris Piell
Sr MD & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct | 3,088 Added 9.05% |
$674,820
$218.53 p/Share
|
Sep 16
2024 |
CME
|
Lynne Fitzpatrick
Sr MD Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 3,604 Added 17.61% |
$787,582
$218.53 p/Share
|
Sep 16
2024 |
IBEX
|
Pine Bridge Gem Ii G.P., L.P. |
SELL
Open market or private sale
|
Indirect | 20,000 Reduced 0.0% |
$403,200
$20.16 p/Share
|
Sep 16
2024 |
CME
|
Sunil Cutinho
Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct | 3,604 Added 10.25% |
$787,582
$218.53 p/Share
|
Sep 16
2024 |
CME
|
Ken Vroman
Chief Transformation Officer |
BUY
Grant, award, or other acquisition
|
Direct | 3,088 Added 12.42% |
$674,820
$218.53 p/Share
|
Sep 16
2024 |
CME
|
Suzanne Sprague
Sr MD Global Head of Clearing |
BUY
Grant, award, or other acquisition
|
Direct | 3,088 Added 24.46% |
$674,820
$218.53 p/Share
|
Sep 16
2024 |
LPSN
|
John De Neen Collins
CFO and COO |
SELL
Open market or private sale
|
Direct | 85,126 Reduced 22.84% |
$89,382
$1.05 p/Share
|
Sep 16
2024 |
ELS
|
Marguerite M Nader
President and CEO |
SELL
Open market or private sale
|
Direct | 33,000 Reduced 11.23% |
$2,492,160
$75.52 p/Share
|
Sep 16
2024 |
MRVL
|
Matthew J Murphy
Chairman of the Board and CEO |
SELL
Open market or private sale
|
Direct | 6,000 Reduced 2.79% |
$439,740
$73.29 p/Share
|
Sep 16
2024 |
HIMS
|
Irene Becklund
PAO |
SELL
Open market or private sale
|
Direct | 472 Reduced 3.02% |
$7,764
$16.45 p/Share
|
Sep 16
2024 |
HIMS
|
Irene Becklund
PAO |
BUY
Exercise of conversion of derivative security
|
Direct | 472 Added 2.94% |
$4,441
$9.41 p/Share
|
Sep 16
2024 |
LBRT
|
Christopher A Wright
Chairman of the Board and CEO |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 0.74% |
$398,200
$19.91 p/Share
|
Sep 16
2024 |
ACEL
|
Andrew H. Rubenstein
CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct | 2,448 Reduced 0.06% |
$28,739
$11.74 p/Share
|
Sep 16
2024 |
ACEL
|
Andrew H. Rubenstein
CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct | 5,614 Added 0.13% |
-
|
Sep 16
2024 |
ACEL
|
Mathew Scot Ellis
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 216 Reduced 0.38% |
$2,535
$11.74 p/Share
|
Sep 16
2024 |
ACEL
|
Mathew Scot Ellis
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 736 Added 1.26% |
-
|
Sep 16
2024 |
ACEL
|
Derek Harmer
Secretary |
SELL
Payment of exercise price or tax liability
|
Direct | 593 Reduced 0.32% |
$6,961
$11.74 p/Share
|
Sep 16
2024 |
ACEL
|
Derek Harmer
Secretary |
BUY
Exercise of conversion of derivative security
|
Direct | 2,021 Added 1.07% |
-
|
Sep 16
2024 |
ACEL
|
Derek Harmer
Secretary |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 5.14% |
$116,400
$11.64 p/Share
|
Sep 16
2024 |
CRWD
|
Shawn Henry
CHIEF SECURITY OFFICER |
SELL
Open market or private sale
|
Direct | 4,500 Reduced 2.51% |
$1,171,980
$260.44 p/Share
|
Sep 16
2024 |
FNKO
|
Yves Le Pendeven
CFO |
SELL
Open market or private sale
|
Direct | 1,344 Reduced 3.97% |
$15,845
$11.79 p/Share
|
Sep 16
2024 |
FNKO
|
Andrew David Oddie
CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 300 Added 0.73% |
$1,203
$4.01 p/Share
|
Sep 16
2024 |
FNKO
|
Andrew David Oddie
CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 300 Reduced 0.74% |
$3,611
$12.04 p/Share
|
Sep 16
2024 |
MRVL
|
Willem A Meintjes
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 1,500 Reduced 1.32% |
$110,805
$73.87 p/Share
|
Sep 16
2024 |
ANAB
|
Dennis Mulroy
CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 40.41% |
$201,600
$20.16 p/Share
|
Sep 16
2024 |
ANAB
|
Dennis Mulroy
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 12,220 Reduced 72.03% |
$483,056
$39.53 p/Share
|
Sep 16
2024 |
NTNX
|
David Sangster
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 11,950 Reduced 8.8% |
$714,968
$59.83 p/Share
|
Sep 16
2024 |
ANAB
|
Paul F. Lizzul
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 2,220 Reduced 12.6% |
$86,424
$38.93 p/Share
|
Sep 16
2024 |
ANAB
|
Eric J Loumeau
CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 5,000 Added 27.0% |
$70,100
$14.02 p/Share
|
Sep 16
2024 |
ANAB
|
Eric J Loumeau
CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct | 8,720 Reduced 55.4% |
$344,701
$39.53 p/Share
|
Sep 16
2024 |
ZG
|
Thielke Claire Cormier
Director |
SELL
Open market or private sale
|
Direct | 2,826 Reduced 50.0% |
$172,696
$61.11 p/Share
|
Sep 16
2024 |
TCNNF
|
Kim A. Rivers
Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 845,516 Reduced 30.15% |
$9,571,241
$11.32 p/Share
|
Sep 16
2024 |
MRVL
|
Chris Koopmans
EVP, Chief Operations Officer |
SELL
Open market or private sale
|
Indirect | 6,000 Reduced 0.0% |
$443,220
$73.87 p/Share
|
Sep 16
2024 |
SBUX
|
Sara Kelly
evp, chief partner officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,525 Reduced 3.29% |
$146,872
$96.31 p/Share
|
Sep 16
2024 |
SBUX
|
Brian R Niccol
chairman and ceo |
BUY
Grant, award, or other acquisition
|
Direct | 332,260 Added 50.0% |
-
|
Sep 16
2024 |
CPSS
|
John Patrick Harton
Sr. Vice President |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 3.77% |
$95,000
$9.5 p/Share
|
Sep 16
2024 |
CPSS
|
Greg Washer
Director |
SELL
Open market or private sale
|
Direct | 40,000 Reduced 12.66% |
$380,000
$9.5 p/Share
|
Sep 16
2024 |
EBAY
|
Stephen J Priest
SVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 26.22% |
$1,602,250
$64.09 p/Share
|
Sep 16
2024 |
EQ
|
Penny Tom
Principal Accounting Officer |
SELL
Open market or private sale
|
Direct | 38,806 Reduced 79.43% |
$32,985
$0.85 p/Share
|
Sep 16
2024 |
DVA
|
Javier Rodriguez
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 5.63% |
$8,252,500
$165.05 p/Share
|
Sep 16
2024 |
DVA
|
Joel Ackerman
CFO and Treasuer |
BUY
Exercise of conversion of derivative security
|
Direct | 78,999 Added 29.84% |
$5,999,974
$75.95 p/Share
|
Sep 16
2024 |
DVA
|
Joel Ackerman
CFO and Treasuer |
SELL
Payment of exercise price or tax liability
|
Direct | 21,602 Reduced 14.49% |
$3,533,223
$163.56 p/Share
|
Sep 16
2024 |
DVA
|
Joel Ackerman
CFO and Treasuer |
SELL
Sale (or disposition) back to the issuer
|
Direct | 36,684 Reduced 19.75% |
$6,000,035
$163.56 p/Share
|
Sep 16
2024 |
SYK
|
M Kathryn Fink
VP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 7,347 Added 29.7% |
$900,080
$122.51 p/Share
|
Sep 16
2024 |
JCI
|
George Oliver
Chairman & CEO |
SELL
Open market or private sale
|
Direct | 110,615 Reduced 8.17% |
$8,038,392
$72.67 p/Share
|
Sep 16
2024 |
JCI
|
George Oliver
Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 110,615 Added 7.55% |
$4,630,343
$41.86 p/Share
|
Sep 16
2024 |
AMRK
|
Gregory N Roberts
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 22,000 Reduced 43.82% |
$997,480
$45.34 p/Share
|
Sep 16
2024 |